Andrew Hamer
Chief Tech/Sci/R&D Officer bei CARDIOL THERAPEUTICS INC.
Vermögen: 433 278 $ am 31.03.2024
Profil
Andrew Hamer is currently the Chief Medical Officer and Head of Research & Development at Cardiol Therapeutics, Inc. Prior to this, he worked at Amgen, Inc. as the Executive Director of Global Development from 2018 to 2021.
He also held the position of Vice President of Medical Affairs at Capricor, Inc. and Capricor Therapeutics, Inc. from 2013 to 2015.
Dr. Hamer completed his undergraduate degree at the University of Otago.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.02.2024 | 239 380 ( 0,37% ) | 433 278 $ | 31.03.2024 |
Aktive Positionen von Andrew Hamer
| Unternehmen | Position | Beginn |
|---|---|---|
| CARDIOL THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 29.03.2021 |
Ehemalige bekannte Positionen von Andrew Hamer
| Unternehmen | Position | Ende |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01.03.2021 |
| CAPRICOR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30.07.2015 |
Capricor, Inc.
 Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Andrew Hamer
| University of Otago | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| CARDIOL THERAPEUTICS INC. | Health Technology |
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Health Technology |
